Key facts
- This page summarizes Jane E. Kiernan's Form 4 filing for Axonics, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 22 Aug 2022, 20:14.
Jane E. Kiernan - 18 Aug 2022 Form 4 Insider Report for Axonics, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 18 Aug 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 22 Aug 2022, 20:14:04 UTC
- Prior SEC filing
- 31 Mar 2022
- Next SEC filing
- 04 Oct 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dan Dearen, as Attorney-in-Fact for Jane E. Kiernan
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jane E. Kiernan filed Form 4 for Axonics, Inc. on 22 Aug 2022.
Change
- Previous filing in this sequence was filed on 31 Mar 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AXNX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +2,100
- Change %
- +14%
- Price
- $0.000000
- Shares after
- 16,861
- Date
- 18 Aug 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.